Pharma
Diverse panel of novel target binders from IONTAS / FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline
| 1 min read
The DynaDrive portfolio offers features that support cell culture performance across scales and accommodate high-density and next-generation cell culture processes
| 2 min read
Preliminary results show that the vaccine has performed well in animal studies, and clinical testing in humans will start within a few months
| 2 min read
Flexibility in design of permanent, modular, and mobile cleanrooms is second to rigorous standards of cleanliness class
| 4 min read
The new QuasIR 2000 with large area probe is very versatile and can be used for many different applications
| 1 min read
License to Nobel prize-winning CRISPR technology supports internal research and development
| 1 min read
The funding will be used to develop and test advanced cell culture models that represent different regions of the lung
| 2 min read
Acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide
| 2 min read
New therapy appears to stop replication of both flu viruses and the virus that causes COVID-19, and could be easily delivered at home
| 4 min read
